NEU neuren pharmaceuticals limited

It controls your downside risk until such time as favourable...

  1. 2,737 Posts.
    lightbulb Created with Sketch. 1050
    It controls your downside risk until such time as favourable conditions exist.

    Let's say a Fund wants to take a position. They like the long term potential of NEU but don't see any reason for a significant re-rate in the near term (or are worried about sector or poor market conditions being a drag on the stock). Looking at NEU price leading up to and post announcing it's Ph3 start for trof provides a good reference point for this. But the fund also doesn't want to try and build a position when everyone is clamouring for the stock in 2 years time either. So they build a position and hedge their downside risk because lord knows you don't want to be holding too many positions in your fund that are down 50%. Won't have much FUM left if that keeps happening. Fund managers try and smooth out volatility and risk and 'hedging' of long positions is one way to do that.

    I think we can all agree that the majority of returns to be made in NEU in the next 2 years will be post Ph 3 results, presuming they are good. I can't see us re-rating above $30 on Daybue results results alone, not in the next 2 years anyway, unless Acadia smash it out of the park.
    Last edited by nashezz: 09/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.